Rigel Pharmaceuticals (RIGL) Research & Development (2016 - 2025)
Historic Research & Development for Rigel Pharmaceuticals (RIGL) over the last 16 years, with Q3 2025 value amounting to $7.4 million.
- Rigel Pharmaceuticals' Research & Development rose 1894.21% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.2 million, marking a year-over-year increase of 3490.97%. This contributed to the annual value of $23.4 million for FY2024, which is 465.7% down from last year.
- As of Q3 2025, Rigel Pharmaceuticals' Research & Development stood at $7.4 million, which was up 1894.21% from $6.8 million recorded in Q2 2025.
- Rigel Pharmaceuticals' Research & Development's 5-year high stood at $18.3 million during Q3 2021, with a 5-year trough of $3.2 million in Q4 2023.
- Moreover, its 5-year median value for Research & Development was $8.4 million (2025), whereas its average is $10.3 million.
- Per our database at Business Quant, Rigel Pharmaceuticals' Research & Development crashed by 7926.46% in 2023 and then surged by 7677.34% in 2024.
- Quarter analysis of 5 years shows Rigel Pharmaceuticals' Research & Development stood at $13.3 million in 2021, then grew by 15.49% to $15.4 million in 2022, then tumbled by 79.26% to $3.2 million in 2023, then skyrocketed by 76.77% to $5.6 million in 2024, then soared by 30.56% to $7.4 million in 2025.
- Its Research & Development was $7.4 million in Q3 2025, compared to $6.8 million in Q2 2025 and $8.4 million in Q1 2025.